In our final newsletter of 2024, we highlight our collaboration with cutting-edge cell-line specialists inscreenex to define TGF beta family activity; celebrate efforts to unite the UK stem cell community and if you are quick, you can benefit from our end-of-year promotion and receive a third free growth factor when you buy two products, a great chance to stock up.
In this edition, we are excited to announce two new distributor agreements, our products will now be available in Türkiye and SLS will be making our products more accessible in the UK and Ireland. Our latest offer, buy 2 get 1 free and other news, the launch of our high quality food grade range.
In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.
In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.
In this edition, we are excited to discuss our conversations at ISSCR 2024 about the stem cell science supply chain and impact of growth factors and cytokines quality on reproducibility, including how to integrate new technologies, such as controlled-release and thermostable proteins. We are also pleased to announce our collaboration with the superb team at StemCultures, launch high quality food grade PDGF-BB, publish a new application note focusing on dopaminergic neuron differentiation and welcome to our team Paul Grafham, CFO and Rob Nixon, Commercial Director.
In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.
Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.
Commercial sources of recombinant human GDF15 protein, in particular those purified from mammalian expression, are frequently contaminated with trace amounts of TGFβ and related proteins. These trace contaminants cause misleading experimental results due to the picomolar or even femtomolar EC50s of this family of cytokines. Please be cautious with your source of recombinant GDF15 protein.
Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.
The manufacture of cell and gene therapy products and tissue-engineered regenerative medicine products often requires recombinant proteins such as growth factors and cytokines. These are classified as raw or ancillary materials ie. culture media components or reagents that are not intended to be included in the final product.
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
